The purpose of this study is to assess the safety and efficacy of daily morning exposure to colored light in patients receiving acute inpatient rehabilitation services for stroke, traumatic brain injury, or non-traumatic brain injury with sleep disturbances such as poor nighttime sleep and/or excessive daytime sleepiness.In a two-arm randomized placebo-controlled study with pre-exposure and post-exposure assessments, we are comparing the effects of daily morning exposure to either blue light or red light on objective sleep quality, subjective sleep quality, functional rehabilitation outcomes, cognitive symptoms, fatigue, and neurological symptoms.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
52
Exposure to daily morning colored light in the 440-485 nm wavelength range
Exposure to daily morning colored light in the 625-740 nm wavelength range
St. Luke's Rehabilitation Institute
Spokane, Washington, United States
RECRUITINGTotal Sleep Time
24/7 recording of total amount of time asleep via wrist-worn actigraph
Time frame: From day of consent through study completion at discharge from inpatient rehabilitation, assessed for at least 10 days
Sleep Efficiency
Recording of the proportion of time asleep relative to time in bed via wrist-worn actigraph
Time frame: From day of consent through study completion at discharge from inpatient rehabilitation, assessed for at least 10 days
Sleep Fragmentation Index
Recording of restlessness during a sleep period via wrist-worn actigraph
Time frame: From day of consent through study completion at discharge from inpatient rehabilitation, assessed for at least 10 days
Frequency of Daytime Naps
Recording of number of naps during daytime via wrist-worn actigraph
Time frame: From day of consent through study completion at discharge from inpatient rehabilitation, assessed for at least 10 days
Karolinska Sleepiness Scale
Patient-report measure of daytime sleepiness
Time frame: Baseline and every 3 days plus at study completion, at least 10 days after consent
Wits Pictorial Sleepiness Scale
Patient-report measure of daytime sleepiness
Time frame: Baseline and every 3 days plus at study completion, at least 10 days after consent
Fatigue Visual Analog Scale
Patient-report measure of global fatigue
Time frame: Baseline and every 3 days plus at study completion, at least 10 days after consent
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.